Jubilant Ingrevia aims for threefold revenue growth by FY30

Jubilant Ingrevia (JUBLINGREA.BO) outlined its "Pinnacle 345" strategy, projecting revenue to reach ₹10,000-₹12,000 crore by FY30, up from approximately ₹4,200 crore in the trailing twelve months of FY24, with EBITDA targeted at ₹2,000 crore. The company aims to increase its ROCE to 17-20% through portfolio shifts towards specialty chemicals and nutrition businesses, cost optimization delivering ₹100 crore+ annual savings, and disciplined capital allocation with a minimum 20% return.